CLDX
Price
$17.38
Change
+$0.53 (+3.15%)
Updated
Apr 2 closing price
Capitalization
1.15B
28 days until earnings call
CLYM
Price
$1.21
Change
+$0.01 (+0.83%)
Updated
Apr 2, 04:59 PM (EDT)
Capitalization
81.65M
46 days until earnings call
Ad is loading...

CLDX vs CLYM

Header iconCLDX vs CLYM Comparison
Open Charts CLDX vs CLYMBanner chart's image
Celldex Therapeutics
Price$17.38
Change+$0.53 (+3.15%)
Volume$707.34K
Capitalization1.15B
Climb Bio
Price$1.21
Change+$0.01 (+0.83%)
Volume$2.12K
Capitalization81.65M
CLDX vs CLYM Comparison Chart
Loading...
CLDX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CLYM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CLDX vs. CLYM commentary
Apr 03, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CLDX is a StrongBuy and CLYM is a Buy.

Ad is loading...
COMPARISON
Comparison
Apr 03, 2025
Stock price -- (CLDX: $17.38 vs. CLYM: $1.21)
Brand notoriety: CLDX and CLYM are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CLDX: 89% vs. CLYM: 42%
Market capitalization -- CLDX: $1.15B vs. CLYM: $81.65M
CLDX [@Biotechnology] is valued at $1.15B. CLYM’s [@Biotechnology] market capitalization is $81.65M. The market cap for tickers in the [@Biotechnology] industry ranges from $308.32B to $0. The average market capitalization across the [@Biotechnology] industry is $2.19B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CLDX’s FA Score shows that 0 FA rating(s) are green whileCLYM’s FA Score has 1 green FA rating(s).

  • CLDX’s FA Score: 0 green, 5 red.
  • CLYM’s FA Score: 1 green, 4 red.
According to our system of comparison, CLYM is a better buy in the long-term than CLDX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CLDX’s TA Score shows that 4 TA indicator(s) are bullish while CLYM’s TA Score has 5 bullish TA indicator(s).

  • CLDX’s TA Score: 4 bullish, 4 bearish.
  • CLYM’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, CLYM is a better buy in the short-term than CLDX.

Price Growth

CLDX (@Biotechnology) experienced а -11.19% price change this week, while CLYM (@Biotechnology) price change was -6.92% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -5.26%. For the same industry, the average monthly price growth was -7.43%, and the average quarterly price growth was -11.99%.

Reported Earning Dates

CLDX is expected to report earnings on May 01, 2025.

CLYM is expected to report earnings on May 19, 2025.

Industries' Descriptions

@Biotechnology (-5.26% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CLDX($1.15B) has a higher market cap than CLYM($81.6M). CLDX YTD gains are higher at: -31.223 vs. CLYM (-33.333). CLYM has higher annual earnings (EBITDA): -24.57M vs. CLDX (-191.9M). CLDX has more cash in the bank: 725M vs. CLYM (193M). CLYM has less debt than CLDX: CLYM (58K) vs CLDX (3.81M). CLDX has higher revenues than CLYM: CLDX (7.02M) vs CLYM (0).
CLDXCLYMCLDX / CLYM
Capitalization1.15B81.6M1,414%
EBITDA-191.9M-24.57M781%
Gain YTD-31.223-33.33394%
P/E RatioN/AN/A-
Revenue7.02M0-
Total Cash725M193M376%
Total Debt3.81M58K6,574%
FUNDAMENTALS RATINGS
CLDX: Fundamental Ratings
CLDX
OUTLOOK RATING
1..100
64
VALUATION
overvalued / fair valued / undervalued
1..100
57
Fair valued
PROFIT vs RISK RATING
1..100
66
SMR RATING
1..100
96
PRICE GROWTH RATING
1..100
89
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CLDXCLYM
RSI
ODDS (%)
Bullish Trend 2 days ago
77%
Bullish Trend 6 days ago
71%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
84%
Bullish Trend 2 days ago
75%
Momentum
ODDS (%)
Bearish Trend 2 days ago
80%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bearish Trend 2 days ago
86%
Bullish Trend 6 days ago
73%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
83%
Bearish Trend 2 days ago
90%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
83%
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
Bullish Trend 22 days ago
84%
Bullish Trend 10 days ago
77%
Declines
ODDS (%)
Bearish Trend 2 days ago
80%
Bearish Trend 2 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
79%
Bullish Trend 2 days ago
89%
Aroon
ODDS (%)
Bearish Trend 2 days ago
84%
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Ad is loading...
CLDX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CLYM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
BBHLX17.850.06
+0.34%
BBH Partner Fund - International Eq I
RIGFX38.910.05
+0.13%
American Funds Intl Gr and Inc R5
EATVX40.00N/A
N/A
Eaton Vance Tx-Mgd Value A
JABYX9.05N/A
N/A
JHancock Global Environmental Opps C
PRCFX27.17N/A
N/A
T. Rowe Price Cap Apprec And Inc

CLYM and

Correlation & Price change

A.I.dvisor indicates that over the last year, CLYM has been loosely correlated with RLYB. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if CLYM jumps, then RLYB could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CLYM
1D Price
Change %
CLYM100%
-1.64%
RLYB - CLYM
41%
Loosely correlated
-6.80%
LRMR - CLYM
31%
Poorly correlated
-6.98%
CLDX - CLYM
30%
Poorly correlated
-7.16%
ELVN - CLYM
30%
Poorly correlated
-4.07%
CMRX - CLYM
28%
Poorly correlated
-0.12%
More